| Income Statement |
| Total Revenue | 15.33M |
|
| Revenues (USD) | 15.33M |
| Cost of Revenue | 10.58M |
| Gross Profit | 4.75M |
| Operating Expenses | 4.63M |
| Research and Development Expense | 947.00K |
| Selling, General and Administrative Expense | 3.68M |
| Operating Income | 121.00K |
| Interest Expense | 279.00K |
| Net Income | -158.00K |
| Net Income Common Stock | -158.00K |
| Net Income Common Stock (USD) | -158.00K |
| Consolidated Income | -158.00K |
| Earning Before Interest & Taxes (EBIT) | 121.00K |
| Earning Before Interest & Taxes (USD) | 121.00K |
| Weighted Average Shares | 70.64M |
| Weighted Average Shares Diluted | 70.64M |
| Balance Sheet |
| Cash and Equivalents | 1.05M |
| Cash and Equivalents (USD) | 1.05M |
| Trade and Non-Trade Receivables | 9.35M |
| Current Assets | 25.27M |
| Property, Plant & Equipment Net | 21.13M |
| Total Assets | 46.44M |
| Debt Current | 15.63M |
| Total Debt | 22.70M |
| Current Liabilities | 26.01M |
| Debt Non-Current | 7.07M |
| Total Liabilities | 33.28M |
| Accumulated Retained Earnings (Deficit) | -103.31M |
| Shareholders Equity | 13.15M |
| Shareholders Equity (USD) | 13.15M |
| Assets Non-Current | 21.17M |
| Total Debt (USD) | 22.70M |
| Deferred Revenue | 1.94M |
| Inventory | 12.96M |
| Liabilities Non-Current | 7.27M |
| Trade and Non-Trade Payables | 4.97M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 323.00K |
| Net Cash Flow from Financing | 751.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 473.00K |
| Capital Expenditure | -469.00K |
| Issuance (Purchase) of Equity Shares | 11.00K |
| Issuance (Repayment) of Debt Securities | 740.00K |
| Net Cash Flow from Investing | -469.00K |
| Net Cash Flow from Operations | 191.00K |
| Share Based Compensation | 79.00K |